MoonLake Immunotherapeutics (MLTX) Q1 2026 Earnings

Feb 22Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.1
-0.94
-0.79
-0.63

Details

Expected EPS
-0.964138
Actual EPS
-0.93
Surprise EPS
0.03
Surprise Percent
+3.54%

Description

⁨MoonLake Immunotherapeutics⁩ (⁦MLTX⁩) has reported earnings of ⁦-0.93⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts